Clinical Trial Update: A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cabiralizumab with nivolumab, with or without chemotherapy, in patients with advanced pancreatic cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Cabiralizumab
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Advanced Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-07-23